Mirum Pharmaceuticals, Inc. announced that on April 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 25,950 shares of common stock and 12,960 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan.
